Journal ArticleOPEN ACCESS

Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report

Therapeutic Advances in Infectious Disease (2020) 7
DOI: 10.1177/2049936120952605
3Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

High-dose tigecycline therapy is gaining wide acceptance in treating infections caused by multidrug-resistant bacteria. There are no reports of cutaneous hyperpigmentation with the use of high-dose tigecycline. Here we report a case of a woman who developed reversible cutaneous hyperpigmentation within 48 h of receiving high-dose tigecycline.

Author supplied keywords

Cite

CITATION STYLE

APA

Alsemari, M. A., Hakeam, H. A., Alsalman, H., & Amin, T. (2020). Cutaneous Hyperpigmentation Secondary to High-Dose Tigecycline: A Case Report. Therapeutic Advances in Infectious Disease, 7. https://doi.org/10.1177/2049936120952605

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free